# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-24-009857
Filing Date
2024-03-28
Accepted
2024-03-28 16:45:57
Documents
69
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | dyai20231231_10k.htm iXBRL | 10-K | 1401604
2 | EXHIBIT 10.2.1 | ex_642498.htm | EX-10.21 | 59890
3 | EXHIBIT 10.2.2 | ex_642499.htm | EX-10.22 | 56116
4 | EXHIBIT 21.1 | ex_642846.htm | EX-21.1 | 1012
5 | EXHIBIT 23.1 | ex_638430.htm | EX-23.1 | 3483
6 | EXHIBIT 23.2 | ex_645081.htm | EX-23.2 | 2470
7 | EXHIBIT 31.1 | ex_599786.htm | EX-31.1 | 13641
8 | EXHIBIT 31.2 | ex_599787.htm | EX-31.2 | 13758
9 | EXHIBIT 32.1 | ex_599788.htm | EX-32.1 | 4899
10 | EXHIBIT 32.2 | ex_599789.htm | EX-32.2 | 4787
11 | EXHIBIT 97 | ex_638431.htm | EX-97 | 33972
17 |  | dyai20201008_10kimg001.jpg | GRAPHIC | 1667
18 |  | orgchart.jpg | GRAPHIC | 74558
| Complete submission text file | 0001437749-24-009857.txt |  | 6909866

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA | dyai-20231231.xsd | EX-101.SCH | 50887
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dyai-20231231_cal.xml | EX-101.CAL | 49581
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dyai-20231231_def.xml | EX-101.DEF | 404036
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dyai-20231231_lab.xml | EX-101.LAB | 362562
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dyai-20231231_pre.xml | EX-101.PRE | 425042
73 | EXTRACTED XBRL INSTANCE DOCUMENT | dyai20231231_10k_htm.xml | XML | 984012

Mailing Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477
Business Address 1044 NORTH U.S. HIGHWAY ONE SUITE 201 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32513 | Film No.: 24799889
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)